{
  "id": "b4685a51c9f125eb",
  "title": "Novo Nordisk Calls Semaglutide Knockoff Illegal , Risky",
  "description": "20260206T021500Z",
  "content": "",
  "source": "medscape.com",
  "source_url": "https://www.medscape.com/viewarticle/novo-nordisk-calls-semaglutide-knockoff-illegal-risky-2026a10003rf",
  "published_at": "20260206T021500Z",
  "fetched_at": "2026-02-07T00:27:41.919994+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.medscape.com/viewarticle/novo-nordisk-calls-semaglutide-knockoff-illegal-risky-2026a10003rf",
    "url_mobile": "",
    "title": "Novo Nordisk Calls Semaglutide Knockoff Illegal , Risky",
    "seendate": "20260206T021500Z",
    "socialimage": "https://img.medscapestatic.com/vim/live/professional_assets/medscape/images/thumbnail_library/dt_230322_semaglutide_800x450.jpg",
    "domain": "medscape.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}